Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Bullboard Posts
Comment by fringelifeon May 28, 2017 9:44pm
66 Views
Post# 26294282

RE:clone shipper $$$$$$$

RE:clone shipper $$$$$$$Even when competition sells clones, THC Biomed takes a cut.

Greencash wrote:

Peace Naturals to begin selling clones

Registered patients will soon be able to order up to 5 clones from the Ontario cannabis producer

Ontario’s Peace Naturals has added cannabis clones to its available products for registered patients. It is the sixth company now to offer clones for sale after Health Canada changed the rules to allow the sale of ‘starting materials’ from licensed cannabis producers to registered patients.

Peace Naturals will be initially offering one strain for sale, Daybreak, at a rate of $75 for the first strain and $50 each addition clone, up to five plants, plus shipping and handling, etc. They also include education materials as part of the starter kit. Like several other producers, Peace Naturals will be using the CloneShipper and using Purolator for overnight shipment.

“This will take people through all the details from receiving their clones all the way to harvest,” says Eric Klein, Marketing & Communications for Cronos Group, which owns a controlling interest in several licensed producers, including Peace Naturals.

“From choosing a grow tent to lighting, air flow, soil selection, nutrient selection, regulating pH, soil preparation...watering and feeding, nutrient systems, we talk about how to leverage those systems, the veg phase, flower phase, harvesting, trimming and curing.”

Klein says they are also working on some video content for registered patients. Peace Naturals have already reached out to patients who have expressed an interest, and they will posting the information on their website soon for registered patients.

Canna FarmsMariCann, Whistler Medical, THC Biomed, and Delta 9 Biotech have also begun selling clones since the August 2016 rule change. Only two Licensed Producers are currently selling seeds: Tweed and CannTrust.

Peace Naturals also announced recently that they received GMP certification by German regulators for distribution in the European Union. GMP, or Good Manufacturing Practices are a set of regulations for a high level of consistent quality standards.

Under Health Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR), Canadian medical cannabis producers have to follow similar Good Production Practices (GPP) . The difference between GPP and GMP is that under GMP all products are required to be consistent, whereas under GPP some inconsistency (for example, in cannabinoid levels between batches) is allowed.



Bullboard Posts